Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Lake Bioscience CoSHSE:600866 -0.60%70 PB Ratio is 1.02 as of Jul. 17, 2026, which is 52% below its 10-year median of 2.13. GuruFocus rates SHSE:600866 with a GF Score™ of 70/100 and a GF Value™ of ¥5.86 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,227 Biotechnology companies, Star Lake Bioscience Co ranks better than 82.15% on this metric.
Star Lake Bioscience Co Inc stock PB Ratio (=0.94) is close to 2-year low of 0.89.
The historical rank and industry rank for Star Lake Bioscience Co's PB Ratio or its related term are showing as below:
SHSE:600866'
s PB Ratio Range Over the Past 10 Years
Min: 0.84 Med: 2.13 Max: 6.16
Current: 1.02
During the past 13 years, Star Lake Bioscience Co's highest PB Ratio was 6.16. The lowest was 0.84. And the median was 2.13.
SHSE:600866's PB Ratio is ranked better than 82.15% of 1227
companies
in the Biotechnology industry
Industry Median: 2.82
vs SHSE:600866: 1.02
During the past 12 months, Star Lake Bioscience Co's average Book Value Per Share Growth Rate was -2.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 16.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Star Lake Bioscience Co was 54.30% per year. The lowest was -15.80% per year. And the median was 8.00% per year.
Back to Basics: PB Ratio
Star Lake Bioscience Co (SHSE:600866) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600866 vs VRTX, REGN, ALNY: PB Ratio Comparison
For the Biotechnology subindustry, Star Lake Bioscience Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Lake Bioscience Co PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Star Lake Bioscience Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Star Lake Bioscience Co (SHSE:600866) has a PB Ratio of 1.02 as of Jul. 17, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Star Lake Bioscience Co and its competitors. This is 52% below median its historical median of 2.13. Over the past decade, Star Lake Bioscience Co's PB Ratio has ranged from 0.84 to 6.16. According to the industry distribution chart, Star Lake Bioscience Co ranks #219 out of 1227 companies in the Biotechnology industry, placing it in the top 17.8%.
Is Star Lake Bioscience Co's PB Ratio too high?
Star Lake Bioscience Co's current PB Ratio of 1.02 is 52% below median its 10-year median of 2.13. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 6.16. The Biotechnology industry median PB Ratio is 2.82. Star Lake Bioscience Co's value of 1.02 is 63.8% below this industry median. Based on the distribution chart, Star Lake Bioscience Co ranks #219 out of 1227 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Star Lake Bioscience Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Star Lake Bioscience Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Star Lake Bioscience Co ranks #219 out of 1227 companies for PB Ratio. This places Star Lake Bioscience Co in the top 18% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.82. Star Lake Bioscience Co's value of 1.02 is 63.8% below this benchmark. Historically, Star Lake Bioscience Co's own PB Ratio has ranged from 0.84 to 6.16 over the past decade. While the company's 10-year median is 2.13 vs. the industry median of 2.82, Star Lake Bioscience Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.82, based on 1,227 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Lake Bioscience Co's current PB Ratio of 1.02 is 63.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Star Lake Bioscience Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Lake Bioscience Co's current PB Ratio is 1.02, which is 52% below median its own 10-year median of 2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Lake Bioscience Co stock overvalued right now?
Based on GuruFocus' analysis, Star Lake Bioscience Co (SHSE:600866) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.86, compared to a current price of ¥5.01 — trading 14.5% below its estimated fair value. The current PB Ratio is 1.02, which is 52% below median its 10-year median of 2.13 and 63.8% below the Biotechnology industry median of 2.82. Star Lake Bioscience Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Star Lake Bioscience Co (SHSE:600866), the current PB Ratio is 1.02 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Lake Bioscience Co (SHSE:600866) Overvalued in 2026?
Based on GuruFocus' analysis, Star Lake Bioscience Co stock appears to be undervalued.
The current stock price of ¥5.01 is trading 14.5% below its estimated GF Value™ of ¥5.86.
GuruFocus considers Star Lake Bioscience Co to be Modestly Undervalued.
Key valuation signals for SHSE:600866:
PB Ratio: 1.02 (52% below median its 10-year median of 2.13)
GF Value™: ¥5.86 vs. price of ¥5.01 (14.5% below fair value)
Industry Position: 63.8% below the Biotechnology median (#219 of 1227)
No single metric tells the full story. See the SHSE:600866 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
70GF Score
Get the complete analysis for SHSE:600866
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600866 has been successfully added to your 
